NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2025 | $50,000 | Replaced |
| 2nd Quarter - Amendment | Jul 23, 2025 | $60,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. Priority Review Voucher Reauthorization. Newborn Screening.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
| ALLISON HERRITY | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
| ALLISON HERRITY | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. H.R.1414: Camerons Law. Promising Pathways Act 2.0.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. Advanced Research Projects Agency - Health (ARPA-H) Appropriations. NIH / FDA Appropriations. HHS RIFs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.